AWMS
EW icon

Advocacy Wealth Management Services’s Edwards Lifesciences EW Stock Holding History

Advocacy Wealth Management Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Sell
174,962
-3,199
-2% -$268K 0.58% 38
2026
Q1 		$14.3M Buy
178,161
+44,755
+34% +$3.69M 0.63% 39
2025
Q4 		$11.4M Sell
133,406
-2,184
-2% -$179K 0.48% 50
2025
Q3 		$10.5M Buy
+135,590
New +$10.6M 0.46% 52

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Advocacy Wealth Management Services's EW Position: Q2 2026 in Review

Advocacy Wealth Management Services reduced its Edwards Lifesciences (EW) stake by 1.8% in Q2 2026, selling an estimated $268K and leaving 174,962 shares worth $15.8M. The position accounts for 0.58% of the portfolio, ranked #38.

Advocacy Wealth Management Services first reported a position in EW in Q3 2025 and has held it in 4 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Advocacy Wealth Management Services held 174,962 shares of Edwards Lifesciences worth $15.8M as of Q2 2026.
  • Advocacy Wealth Management Services sold 3,199 Edwards Lifesciences shares in Q2 2026, an estimated $268K.
  • Edwards Lifesciences made up 0.58% of Advocacy Wealth Management Services's portfolio in Q2 2026, its #38 holding.
  • Advocacy Wealth Management Services first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Advocacy Wealth Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.